Physician profile
Jared Liebman
NPI 1760692180
$1,383.00
in general payments reported to CMS, 2019-2025
10 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $283 · 2021: $15.28 · 2022: $140 · 2023: $294 · 2024: $124 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.29 |
| Education | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $584.16 | 2019-2022 | |
| Smith+Nephew, INC. | $406.01 | 2019-2025 | Collagenase Santyl, Stravix, Stravix Pl |
| Abbvie INC. | $115.29 | 2022-2025 | |
| Baxter Healthcare | $71.74 | 2023-2024 | Tisseel |
| Integra Lifesciences Corporation | $60.20 | 2025 | Integra, Surgimend, Omnigraft |
| Allergan, INC. | $54.35 | 2019 | |
| Solventum Corporation | $32.02 | 2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Tei Biosciences INC | $24.45 | 2019 | |
| Davol INC. | $19.78 | 2019 | |
| Mentor Worldwide LLC | $15.00 | 2024 | Mentor Memorygel Resterilizable Gel Sizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Liebman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.